Annual ROE
3.51%
+0.32%+10.03%
31 December 2023
Summary:
BioMarin Pharmaceutical annual return on equity is currently 3.51%, with the most recent change of +0.32% (+10.03%) on 31 December 2023. During the last 3 years, it has fallen by -20.12% (-85.15%). BMRN annual ROE is now -96.34% below its all-time high of 95.88%, reached on 31 December 2005.BMRN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
6.29%
+1.16%+22.61%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly return on equity is currently 6.29%, with the most recent change of +1.16% (+22.61%) on 30 September 2024. Over the past year, it has increased by +3.16% (+100.96%). BMRN quarterly ROE is now -99.17% below its all-time high of 753.35%, reached on 31 March 2005.BMRN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.0% | +101.0% |
| 3 y3 years | -85.2% | +2319.2% |
| 5 y5 years | +231.5% | +539.9% |
BMRN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -85.2% | +329.4% | at high | +513.8% |
| 5 y | 5 years | -85.2% | +231.5% | -75.3% | +513.8% |
| alltime | all time | -96.3% | +100.5% | -99.2% | +101.4% |
BioMarin Pharmaceutical ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 6.29%(+22.6%) |
| June 2024 | - | 5.13%(+21.6%) |
| Mar 2024 | - | 4.22%(+20.2%) |
| Dec 2023 | 3.51%(+10.0%) | 3.51%(+12.1%) |
| Sept 2023 | - | 3.13%(+44.9%) |
| June 2023 | - | 2.16%(+36.7%) |
| Mar 2023 | - | 1.58%(-50.2%) |
| Dec 2022 | 3.19%(-308.5%) | 3.17%(+66.0%) |
| Sept 2022 | - | 1.91%(+52.8%) |
| June 2022 | - | 1.25%(+35.9%) |
| Mar 2022 | - | 0.92%(-160.5%) |
| Dec 2021 | -1.53%(-106.5%) | -1.52%(-684.6%) |
| Sept 2021 | - | 0.26%(-98.8%) |
| June 2021 | - | 21.01%(0.0%) |
| Mar 2021 | - | 21.01%(-12.6%) |
| Dec 2020 | 23.63%(-3129.5%) | 24.05%(-5.6%) |
| Sept 2020 | - | 25.47%(+551.4%) |
| June 2020 | - | 3.91%(+5.1%) |
| Mar 2020 | - | 3.72%(-570.9%) |
| Dec 2019 | -0.78%(-70.8%) | -0.79%(-44.8%) |
| Sept 2019 | - | -1.43%(-62.0%) |
| June 2019 | - | -3.76%(+22.1%) |
| Mar 2019 | - | -3.08%(+14.9%) |
| Dec 2018 | -2.67%(-36.4%) | -2.68%(-39.0%) |
| Sept 2018 | - | -4.39%(-0.7%) |
| June 2018 | - | -4.42%(-14.7%) |
| Mar 2018 | - | -5.18%(+23.6%) |
| Dec 2017 | -4.20%(-82.8%) | -4.19%(-26.1%) |
| Sept 2017 | - | -5.67%(-19.3%) |
| June 2017 | - | -7.03%(-69.1%) |
| Mar 2017 | - | -22.74%(-13.2%) |
| Dec 2016 | -24.39%(+178.7%) | -26.21%(+28.5%) |
| Sept 2016 | - | -20.39%(-12.5%) |
| June 2016 | - | -23.29%(+192.6%) |
| Mar 2016 | - | -7.96%(+1.9%) |
| Dec 2015 | -8.75%(-6.3%) | -7.81%(-49.1%) |
| Sept 2015 | - | -15.34%(+34.4%) |
| June 2015 | - | -11.41%(+17.1%) |
| Mar 2015 | - | -9.74%(+6.1%) |
| Dec 2014 | -9.34%(-37.6%) | -9.18%(+2.6%) |
| Sept 2014 | - | -8.95%(-34.8%) |
| June 2014 | - | -13.73%(+3.5%) |
| Mar 2014 | - | -13.26%(-7.7%) |
| Dec 2013 | -14.97%(+17.1%) | -14.36%(-0.2%) |
| Sept 2013 | - | -14.39%(+33.2%) |
| June 2013 | - | -10.80%(-16.1%) |
| Mar 2013 | - | -12.88%(+3.1%) |
| Dec 2012 | -12.78%(+77.0%) | -12.49%(+22.9%) |
| Sept 2012 | - | -10.16%(-17.9%) |
| June 2012 | - | -12.38%(+27.2%) |
| Mar 2012 | - | -9.73%(+34.4%) |
| Dec 2011 | -7.22% | -7.24%(+30.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | -5.56%(-117.7%) |
| June 2011 | - | 31.37%(-14.4%) |
| Mar 2011 | - | 36.66%(-16.9%) |
| Dec 2010 | 39.60%(<-9900.0%) | 44.10%(-24.0%) |
| Sept 2010 | - | 58.00%(+1459.1%) |
| June 2010 | - | 3.72%(-17.7%) |
| Mar 2010 | - | 4.52%(-2758.8%) |
| Dec 2009 | -0.16%(-101.2%) | -0.17%(-102.4%) |
| Sept 2009 | - | 7.02%(+35.0%) |
| June 2009 | - | 5.20%(-20.4%) |
| Mar 2009 | - | 6.53%(-51.8%) |
| Dec 2008 | 13.28%(-228.4%) | 13.55%(+215.1%) |
| Sept 2008 | - | 4.30%(+190.5%) |
| June 2008 | - | 1.48%(-155.4%) |
| Mar 2008 | - | -2.67%(-72.6%) |
| Dec 2007 | -10.34%(-92.7%) | -9.73%(-49.5%) |
| Sept 2007 | - | -19.26%(-21.8%) |
| June 2007 | - | -24.62%(-12.3%) |
| Mar 2007 | - | -28.07%(-49.4%) |
| Dec 2006 | -141.46%(-247.5%) | -55.43%(-75.2%) |
| Sept 2006 | - | -223.39%(-164.4%) |
| June 2006 | - | 346.84%(+191.8%) |
| Mar 2006 | - | 118.86%(+37.4%) |
| Dec 2005 | 95.88%(-112.8%) | 86.48%(-49.0%) |
| Sept 2005 | - | 169.68%(-30.7%) |
| June 2005 | - | 244.72%(-67.5%) |
| Mar 2005 | - | 753.35%(-265.6%) |
| Dec 2004 | -751.65%(+973.0%) | -454.96%(+189.5%) |
| Sept 2004 | - | -157.17%(+44.7%) |
| June 2004 | - | -108.61%(+96.2%) |
| Mar 2004 | - | -55.36%(+0.3%) |
| Dec 2003 | -70.05%(+16.7%) | -55.19%(+9.0%) |
| Sept 2003 | - | -50.65%(+4.7%) |
| June 2003 | - | -48.39%(-10.0%) |
| Mar 2003 | - | -53.78%(-9.8%) |
| Dec 2002 | -60.03%(+1.9%) | -59.63%(-18.6%) |
| Sept 2002 | - | -73.26%(+3.1%) |
| June 2002 | - | -71.05%(-8.7%) |
| Mar 2002 | - | -77.84%(+7.9%) |
| Dec 2001 | -58.91%(+32.7%) | -72.16%(+30.2%) |
| Sept 2001 | - | -55.43%(+6.9%) |
| June 2001 | - | -51.87%(+12.9%) |
| Mar 2001 | - | -45.96%(+3.6%) |
| Dec 2000 | -44.38%(+1.0%) | -44.38%(+12.7%) |
| Sept 2000 | - | -39.37%(-12.3%) |
| June 2000 | - | -44.87%(-14.0%) |
| Mar 2000 | - | -52.17%(+15.0%) |
| Dec 1999 | -43.94%(+5.0%) | -45.35%(+18.7%) |
| Sept 1999 | - | -38.20%(-28.9%) |
| June 1999 | - | -53.69%(+192.4%) |
| Mar 1999 | - | -18.36% |
| Dec 1998 | -41.84% | - |
FAQ
- What is BioMarin Pharmaceutical annual return on equity?
- What is the all time high annual ROE for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual ROE year-on-year change?
- What is BioMarin Pharmaceutical quarterly return on equity?
- What is the all time high quarterly ROE for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly ROE year-on-year change?
What is BioMarin Pharmaceutical annual return on equity?
The current annual ROE of BMRN is 3.51%
What is the all time high annual ROE for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual return on equity is 95.88%
What is BioMarin Pharmaceutical annual ROE year-on-year change?
Over the past year, BMRN annual return on equity has changed by +0.32% (+10.03%)
What is BioMarin Pharmaceutical quarterly return on equity?
The current quarterly ROE of BMRN is 6.29%
What is the all time high quarterly ROE for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly return on equity is 753.35%
What is BioMarin Pharmaceutical quarterly ROE year-on-year change?
Over the past year, BMRN quarterly return on equity has changed by +3.16% (+100.96%)